Who has invested in Eirion Therapeutics?

Shanghai Haohai Biological Technology Ltd. are named among the investors backing Eirion Therapeutics.

Eirion Therapeutics Funding: $40M Raised, Series A

Eirion Therapeutics funding overview

Eirion Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A. Investors on record include Shanghai Haohai Biological Technology Ltd..

Eirion Therapeutics at a glance

Total raised: $40M
Latest round: Series A
Notable investors: Shanghai Haohai Biological Technology Ltd.

Frequently asked about Eirion Therapeutics funding

How much has Eirion Therapeutics raised?: Eirion Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Eirion Therapeutics?: Shanghai Haohai Biological Technology Ltd. are named among the investors backing Eirion Therapeutics.
What was the latest Eirion Therapeutics funding round?: The most recent disclosed round is a Series A.
Where is Eirion Therapeutics based?: No headquarters location is disclosed for Eirion Therapeutics.

Eirion Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Eirion Therapeutics Funding: $40M Raised, Series A

Eirion Therapeutics funding overview

Eirion Therapeutics at a glance

Frequently asked about Eirion Therapeutics funding

Companies related to Eirion Therapeutics (30)

Browse related funding lists (2)